Biokine: BioLineRx Announces Initiation of Phase 2 Clinical Trial of Motixafortide as First-Line Therapy in Metastatic Pancreatic Cancer – CBI
Homepage /  Press Release /  Biokine: BioLineRx Announces Initiation of Phase 2 Clinical Trial of Motixafortide as First-Line Therapy in Metastatic Pancreatic Cancer

Press Release

Biokine: BioLineRx Announces Initiation of Phase 2 Clinical Trial of Motixafortide as First-Line Therapy in Metastatic Pancreatic Cancer